Beginning Cash: The amount of cash reported by the company on its previous statement.
ALX Oncology Holdings Inc. (ALXO) had Beginning Cash of $17.63M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-22.85M |
|
-- |
|
-- |
|
$23.02M |
|
$-23.02M |
|
$0.17M |
|
$-22.85M |
|
$-22.85M |
|
$-22.85M |
|
$-22.85M |
|
$-22.85M |
|
$-22.85M |
|
$-23.02M |
|
$-22.98M |
|
53.66M |
|
53.66M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$50.73M |
|
$1.20M |
|
$8.32M |
|
$59.05M |
|
$24.55M |
|
$4.53M |
|
$8.51M |
|
$33.06M |
|
$25.98M |
|
$25.98M |
|
$25.98M |
|
54.39M |
|
| Cash Flow Statement Financials | |
$-84.14M |
|
$82.59M |
|
$0.36M |
|
|
Beginning Cash |
$17.63M |
$16.44M |
|
$-1.19M |
|
$12.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
0.15 |
|
0.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-84.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-87.94% |
|
-87.94% |
|
-38.70% |
|
-74.88% |
|
$0.48 |
|
$-1.57 |
|
$-1.57 |
|